Interleukin-10: Cytokines in Anti-inflammation and Tolerance

Interleukin (IL)-10 is an immunosuppressive cytokine produced by many cells of the innate and adaptive immune response, including macrophages, dendritic cells, B cells, and T cells. A major role of IL-10 is to act as a feedback regulator of the immune response by inhibiting the production of inflammatory cytokines by innate cells such as macrophages and dendritic cells. Thus, the production of IL-10 in response to microbial flora is required to inhibit the development of colitis and, during infection, to inhibit an over-exuberant immune response that may potentially result in morbidity and mortality to the host. Thus, appropriate levels of IL-10 should be induced to inhibit host damage, but not to the level that they inhibit a protective immune response to a pathogen which could result in chronic infection. Regulation of the immune response by IL-10 has been shown to play a role in control of allergic, inflammatory, and autoimmune diseases, and further knowledge may advance our ability to use antagonists or agonists of IL-10 for immune therapies.

[1]  S. Matsuda,et al.  Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. , 2008, Blood.

[2]  Kevin Marsh,et al.  Immunity to malaria: more questions than answers , 2008, Nature Immunology.

[3]  D. Strachan,et al.  Sequence variants in IL10, ARPC2 and multiple other loci contribute to ulcerative colitis susceptibility , 2008, Nature Genetics.

[4]  Yi Luo,et al.  Anti-interleukin-10R1 monoclonal antibody enhances bacillus Calmette-Guérin induced T-helper type 1 immune responses and antitumor immunity in a mouse orthotopic model of bladder cancer. , 2012, The Journal of urology.

[5]  Yi Luo Blocking IL-10 enhances bacillus Calmette-Guérin induced T helper Type 1 immune responses and anti-bladder cancer immunity , 2012, Oncoimmunology.

[6]  Richard A Flavell,et al.  The Transcription Factor GATA-3 Is Necessary and Sufficient for Th2 Cytokine Gene Expression in CD4 T Cells , 1997, Cell.

[7]  Y. Belkaid,et al.  CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity , 2002, Nature.

[8]  C. Hunter,et al.  The immunobiology of IL-27. , 2012, Advances in immunology.

[9]  P. Murray Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. , 2006, Current opinion in pharmacology.

[10]  G. Trinchieri,et al.  CD4+ T Cell Clones Producing both Interferon-γ and Interleukin-10 Predominate in Bronchoalveolar Lavages of Active Pulmonary Tuberculosis Patients , 1999 .

[11]  R. J. Hocking,et al.  TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. , 2006, Immunity.

[12]  S. Gordon,et al.  Syk-dependent cytokine induction by Dectin-1 reveals a novel pattern recognition pathway for C type lectins. , 2005, Immunity.

[13]  Margarida Saraiva,et al.  Interleukin-10 Production by Th1 Cells Requires Interleukin-12-Induced STAT4 Transcription Factor and ERK MAP Kinase Activation by High Antigen Dose , 2009, Immunity.

[14]  R. Coffman,et al.  Central Nervous System Expression of IL-10 Inhibits Autoimmune Encephalomyelitis1 , 2001, The Journal of Immunology.

[15]  N. Gow,et al.  Pattern recognition: recent insights from Dectin-1 , 2009, Current opinion in immunology.

[16]  W. Ouyang,et al.  Signaling and transcription in T helper development. , 2000, Annual review of immunology.

[17]  P. Blackshear,et al.  The p38 MAPK pathway inhibits tristetraprolin‐directed decay of interleukin‐10 and pro‐inflammatory mediator mRNAs in murine macrophages , 2009, FEBS letters.

[18]  R. de Waal Malefyt,et al.  The role of interleukin-10 in autoimmune disease: systemic lupus erythematosus (SLE) and multiple sclerosis (MS). , 2002, Cytokine & growth factor reviews.

[19]  K. Rajewsky,et al.  T Cell–specific Inactivation of the Interleukin 10 Gene in Mice Results in Enhanced T Cell Responses but Normal Innate Responses to Lipopolysaccharide or Skin Irritation , 2004, The Journal of experimental medicine.

[20]  D. Sacks,et al.  CD4+CD25−Foxp3− Th1 cells are the source of IL-10–mediated immune suppression in chronic cutaneous leishmaniasis , 2007, The Journal of experimental medicine.

[21]  T. Lawrence,et al.  The kinase p38α serves cell type–specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression , 2008, Nature Immunology.

[22]  A. Rudensky,et al.  Interleukin-10 signaling in regulatory T cells is required for suppression of Th17 cell-mediated inflammation. , 2011, Immunity.

[23]  C. Hawrylowicz,et al.  Strategies for use of IL‐10 or its antagonists in human disease , 2008, Immunological reviews.

[24]  Booki Min,et al.  Conditional deletion of Gata3 shows its essential function in TH1-TH2 responses , 2004, Nature Immunology.

[25]  R. Coffman,et al.  Interleukin-10 and the interleukin-10 receptor. , 2001, Annual review of immunology.

[26]  I. Orme,et al.  In Vivo IL-10 Production Reactivates Chronic Pulmonary Tuberculosis in C57BL/6 Mice1 , 2002, The Journal of Immunology.

[27]  T. Beaty,et al.  Antimetastatic and antitumor activities of interleukin 10 in a murine model of breast cancer. , 1996, Journal of the National Cancer Institute.

[28]  Tom R. Mayo,et al.  Genome-wide Analysis Identifies Interleukin-10 mRNA as Target of Tristetraprolin* , 2008, Journal of Biological Chemistry.

[29]  M. Leach,et al.  Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. , 1996, The Journal of clinical investigation.

[30]  Ching Li,et al.  A Defect in Interleukin-10 Leads to Enhanced Malarial Disease in Plasmodium chabaudi chabaudi Infection in Mice , 1999, Infection and Immunity.

[31]  E. Gambineri,et al.  Role of regulatory T cells and FOXP3 in human diseases. , 2007, The Journal of allergy and clinical immunology.

[32]  G. Trinchieri,et al.  In vivo manipulation of dendritic cell migration and activation to elicit antitumour immunity. , 2004, Novartis Foundation symposium.

[33]  W. Leonard,et al.  Jaks and STATs: biological implications. , 1998, Annual review of immunology.

[34]  T. Mosmann,et al.  Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. , 1990, Science.

[35]  M. Conde,et al.  TheMycobacterium tuberculosis Complex-Restricted Genecfp32 Encodes an Expressed Protein That Is Detectable inTuberculosis Patients and Is Positively Correlated with PulmonaryInterleukin-10 , 2003, Infection and Immunity.

[36]  Samir K. Brahmachari,et al.  Posttranscriptional regulation of interleukin-10 expression by hsa-miR-106a , 2009, Proceedings of the National Academy of Sciences.

[37]  K. Stuhlmeier,et al.  The TSC-mTOR signaling pathway regulates the innate inflammatory response. , 2008, Immunity.

[38]  J. Woodgett,et al.  IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. , 2006, Immunity.

[39]  D. Levy,et al.  IL-21 Mediates Suppressive Effects via Its Induction of IL-101 , 2009, The Journal of Immunology.

[40]  J. Ruland,et al.  Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17 , 2007, Nature Immunology.

[41]  G. Bancroft,et al.  Blockade of IL-10 Signaling during Bacillus Calmette-Guérin Vaccination Enhances and Sustains Th1, Th17, and Innate Lymphoid IFN-γ and IL-17 Responses and Increases Protection to Mycobacterium tuberculosis Infection , 2012, The Journal of Immunology.

[42]  M. Howard,et al.  Continuous administration of anti-interleukin 10 antibodies delays onset of autoimmunity in NZB/W F1 mice , 1994, The Journal of experimental medicine.

[43]  D. Leduc,et al.  Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. , 1995, The Journal of clinical investigation.

[44]  Xia Zhang,et al.  Dynamic and Transient Remodeling of the Macrophage IL-10 Promoter during Transcription1 , 2006, The Journal of Immunology.

[45]  D. Wraith,et al.  Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10–secreting Th1 cells , 2009, The Journal of experimental medicine.

[46]  Shizuo Akira,et al.  Toll-like receptor signalling , 2004, Nature Reviews Immunology.

[47]  G. Bancroft,et al.  Enhanced protection to Mycobacterium tuberculosis infection in IL-10-deficient mice is accompanied by early and enhanced Th1 responses in the lung , 2010, European journal of immunology.

[48]  Laurie H Glimcher,et al.  A Novel Transcription Factor, T-bet, Directs Th1 Lineage Commitment , 2000, Cell.

[49]  Francis J. Huber,et al.  Th17 cells express interleukin-10 receptor and are controlled by Foxp3⁻ and Foxp3+ regulatory CD4+ T cells in an interleukin-10-dependent manner. , 2011, Immunity.

[50]  C. Akdis,et al.  Role of interleukin 10 in specific immunotherapy. , 1998, The Journal of clinical investigation.

[51]  David L. Williams,et al.  Syk‐dependent ERK activation regulates IL‐2 and IL‐10 production by DC stimulated with zymosan , 2007, European journal of immunology.

[52]  J. Langhorne,et al.  T cell-derived IL-10 and its impact on the regulation of host responses during malaria. , 2012, International journal for parasitology.

[53]  D. McGavern,et al.  IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection , 2008, The Journal of experimental medicine.

[54]  S. Rutz,et al.  Regulation and functions of the IL-10 family of cytokines in inflammation and disease. , 2011, Annual review of immunology.

[55]  D. Flaherty,et al.  Interleukin-10 Promotes Mycobacterium tuberculosis Disease Progression in CBA/J Mice1 , 2008, The Journal of Immunology.

[56]  D. Sacks,et al.  Interleukin-10 and the pathogenesis of human visceral leishmaniasis. , 2007, Trends in immunology.

[57]  T. Mosmann,et al.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones , 1989, The Journal of experimental medicine.

[58]  K. Rajewsky,et al.  Interleukin-10-deficient mice develop chronic enterocolitis , 1993, Cell.

[59]  Frank Kaiser,et al.  TPL-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cells , 2009, The Journal of experimental medicine.

[60]  S. Fillatreau Novel regulatory functions for Toll‐like receptor‐activated B cells during intracellular bacterial infection , 2011, Immunological reviews.

[61]  O. Leavy,et al.  Attenuating Regulatory T Cell Induction by TLR Agonists through Inhibition of p38 MAPK Signaling in Dendritic Cells Enhances Their Efficacy as Vaccine Adjuvants and Cancer Immunotherapeutics1 , 2008, The Journal of Immunology.

[62]  P. Barry,et al.  Virus-Encoded Homologs of Cellular Interleukin-10 and Their Control of Host Immune Function , 2016 .

[63]  F. Powrie,et al.  Regulatory lymphocytes and intestinal inflammation. , 2009, Annual review of immunology.

[64]  S. Wenzel,et al.  Interleukin-10 regulation in normal subjects and patients with asthma. , 1996, Journal of Allergy and Clinical Immunology.

[65]  B. Pulendran,et al.  A Toll-Like Receptor 2 Ligand Stimulates Th2 Responses In Vivo, via Induction of Extracellular Signal-Regulated Kinase Mitogen-Activated Protein Kinase and c-Fos in Dendritic Cells 1 , 2004, The Journal of Immunology.

[66]  G. Berry,et al.  CD4 T-helper cells engineered to produce IL-10 prevent allergen-induced airway hyperreactivity and inflammation. , 2002, The Journal of allergy and clinical immunology.

[67]  F. Marincola,et al.  Interleukin‐10 and the immune response against cancer: a counterpoint , 2005, Journal of leukocyte biology.

[68]  D. Raoult,et al.  The two faces of interleukin 10 in human infectious diseases. , 2006, The Lancet. Infectious diseases.

[69]  Lisa M. Toney,et al.  Regulation of IL-10 Gene Expression in Th2 Cells by Jun Proteins1 , 2005, The Journal of Immunology.

[70]  Margarida Saraiva,et al.  The regulation of IL-10 production by immune cells , 2010, Nature Reviews Immunology.

[71]  Gisen Kim,et al.  Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitis , 2009, Nature Immunology.

[72]  Richard A. Flavell,et al.  Conventional T-bet+Foxp3− Th1 cells are the major source of host-protective regulatory IL-10 during intracellular protozoan infection , 2007, The Journal of experimental medicine.

[73]  Georg Kraal,et al.  Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice. , 2003, The Journal of clinical investigation.

[74]  Fiona Powrie,et al.  Intestinal homeostasis and its breakdown in inflammatory bowel disease , 2011, Nature.

[75]  C. Hawrylowicz,et al.  Potential role of interleukin-10-secreting regulatory T cells in allergy and asthma , 2005, Nature Reviews Immunology.

[76]  CM Filippi,et al.  IL‐10 and the resolution of infections , 2008, The Journal of pathology.

[77]  A. O’Garra,et al.  The role of IL-10 in immune regulation during M. tuberculosis infection , 2011, Mucosal Immunology.

[78]  S. Rutz,et al.  Notch regulates IL-10 production by T helper 1 cells , 2008, Proceedings of the National Academy of Sciences.

[79]  P. Murray The primary mechanism of the IL-10-regulated antiinflammatory response is to selectively inhibit transcription. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[80]  R. Sartor,et al.  Resident Enteric Bacteria Are Necessary for Development of Spontaneous Colitis and Immune System Activation in Interleukin-10-Deficient Mice , 1998, Infection and Immunity.

[81]  Christopher A Hunter,et al.  Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10 , 2007, Nature Immunology.

[82]  Christoph Wilhelm,et al.  Transforming growth factor-β 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9–producing subset , 2008, Nature Immunology.

[83]  A. Sher,et al.  In the absence of endogenous IL-10, mice acutely infected with Toxoplasma gondii succumb to a lethal immune response dependent on CD4+ T cells and accompanied by overproduction of IL-12, IFN-gamma and TNF-alpha. , 1996, Journal of immunology.

[84]  D. Littman,et al.  The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells , 2006, Cell.

[85]  T. Wynn,et al.  IL-10 and the Dangers of Immune Polarization: Excessive Type 1 and Type 2 Cytokine Responses Induce Distinct Forms of Lethal Immunopathology in Murine Schistosomiasis , 2000, The Journal of Immunology.

[86]  C. Mauri,et al.  Immune regulatory function of B cells. , 2012, Annual review of immunology.

[87]  P. Handford,et al.  The CD46 and Jagged1 interaction is critical for human T helper 1 immunity , 2012, Nature Immunology.

[88]  T. Mosmann,et al.  Expression of interleukin-10 activity by Epstein-Barr virus protein BCRF1. , 1990, Science.

[89]  C. Weaver,et al.  Diversity in the contribution of interleukin‐10 to T‐cell‐mediated immune regulation , 2008, Immunological reviews.

[90]  Werner Müller,et al.  IL-27 Promotes IL-10 Production by Effector Th1 CD4+ T Cells: A Critical Mechanism for Protection from Severe Immunopathology during Malaria Infection , 2012, The Journal of Immunology.

[91]  Zhihong Wu,et al.  c-Maf Regulates IL-10 Expression during Th17 Polarization1 , 2009, The Journal of Immunology.

[92]  D. Miranda-Saavedra,et al.  Genome-wide analysis of STAT3 binding in vivo predicts effectors of the anti-inflammatory response in macrophages. , 2012, Blood.

[93]  C. Hawrylowicz,et al.  Regulatory T cells in asthma. , 2009, Immunity.

[94]  F. Marincola,et al.  The dual role of IL-10. , 2003, Trends in immunology.

[95]  H. Rugo,et al.  Production of cytokines by mouse B cells: B lymphomas and normal B cells produce interleukin 10. , 1990, International immunology.

[96]  M. Lotze,et al.  Systemic administration of cellular IL-10 induces an effective, specific, and long-lived immune response against established tumors in mice. , 1996, Journal of immunology.

[97]  A. Sher,et al.  IL-10 regulates liver pathology in acute murine Schistosomiasis mansoni but is not required for immune down-modulation of chronic disease. , 1998, Journal of immunology.

[98]  A. O’Garra,et al.  GATA-3 Directly Remodels the IL-10 Locus Independently of IL-4 in CD4+ T Cells , 2006, The Journal of Immunology.

[99]  J. Wain,et al.  A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion , 2006, Proceedings of the National Academy of Sciences.

[100]  Genhong Cheng,et al.  Cutting Edge: Involvement of the Type I IFN Production and Signaling Pathway in Lipopolysaccharide-Induced IL-10 Production1 , 2007, The Journal of Immunology.

[101]  Y. Belkaid,et al.  The Role of Interleukin (IL)-10 in the Persistence of Leishmania major in the Skin after Healing and the Therapeutic Potential of Anti–IL-10 Receptor Antibody for Sterile Cure , 2001, The Journal of experimental medicine.

[102]  A. Schäffer,et al.  Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. , 2009, The New England journal of medicine.

[103]  M. Roederer,et al.  IL-10 production differentially influences the magnitude, quality, and protective capacity of Th1 responses depending on the vaccine platform , 2010, The Journal of experimental medicine.

[104]  Steve Gerondakis,et al.  Diverse Toll-like receptors utilize Tpl2 to activate extracellular signal-regulated kinase (ERK) in hemopoietic cells. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[105]  M. Gilliet,et al.  Generation of Human CD8 T Regulatory Cells by CD40 Ligand–activated Plasmacytoid Dendritic Cells , 2002, The Journal of experimental medicine.

[106]  Jae-Geun Yoon,et al.  Role of Mitogen-Activated Protein Kinases in CpG DNA-Mediated IL-10 and IL-12 Production: Central Role of Extracellular Signal-Regulated Kinase in the Negative Feedback Loop of the CpG DNA-Mediated Th1 Response1 , 2002, The Journal of Immunology.

[107]  M. Dallman,et al.  Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. , 2005, The Journal of clinical investigation.

[108]  Margarida Saraiva,et al.  Identification of a Macrophage-Specific Chromatin Signature in the IL-10 Locus1 , 2005, The Journal of Immunology.

[109]  R. North,et al.  Immunity to tuberculosis. , 2003, Annual review of immunology.

[110]  H. Weiner,et al.  IL-10 is critical in the regulation of automimmune encephalomyelitis as demonstrated by studies of IL-10 and IL-4 deficient and transgenic mice , 1998, Journal of Neuroimmunology.

[111]  H. So,et al.  Interaction of Ets-1 with HDAC1 Represses IL-10 Expression in Th1 Cells , 2012, The Journal of Immunology.

[112]  T. Wynn Fibrotic disease and the TH1/TH2 paradigm , 2004, Nature Reviews Immunology.

[113]  M. Feldmann,et al.  IL-10 inhibits transcription elongation of the human TNF gene in primary macrophages , 2010, The Journal of experimental medicine.

[114]  A. Trautmann,et al.  Modifications of CD8+ T cell function during in vivo memory or tolerance induction. , 1998, Immunity.

[115]  S. Pestka,et al.  Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[116]  W. Haining,et al.  Resolution of a chronic viral infection after interleukin-10 receptor blockade , 2006, The Journal of experimental medicine.

[117]  S. Akira,et al.  Macrophages and Myeloid Dendritic Cells, but Not Plasmacytoid Dendritic Cells, Produce IL-10 in Response to MyD88- and TRIF-Dependent TLR Signals, and TLR-Independent Signals1 , 2006, The Journal of Immunology.

[118]  Tariq Ahmad,et al.  Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci , 2010, Nature Genetics.

[119]  L. Teyton,et al.  Interleukin-10 determines viral clearance or persistence in vivo , 2006, Nature Medicine.

[120]  M. Feldmann,et al.  Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases. , 1998, Journal of immunology.

[121]  Hyun-Dong Chang,et al.  Expression of IL‐10 in Th memory lymphocytes is conditional on IL‐12 or IL‐4, unless the IL‐10 gene is imprinted by GATA‐3 , 2007, European journal of immunology.

[122]  K. Lockridge,et al.  Primate cytomegaloviruses encode and express an IL-10-like protein. , 2000, Virology.

[123]  I. Ho,et al.  Ets-1, a functional cofactor of T-bet, is essential for Th1 inflammatory responses , 2005, The Journal of experimental medicine.

[124]  J. Turner,et al.  Interleukin-10 and Immunity against Prokaryotic and Eukaryotic Intracellular Pathogens , 2011, Infection and Immunity.

[125]  M. Howard,et al.  Ly‐1 B (B‐1) cells are the main source of B cell‐derived interleukin 10 , 1992, European journal of immunology.

[126]  Xia Zhang,et al.  NF-κB1 (p50) Homodimers Differentially Regulate Pro- and Anti-inflammatory Cytokines in Macrophages* , 2006, Journal of Biological Chemistry.